An administrative law judge has upheld a decision barring three former Purdue Pharma executives from participating in federal health care programs for 15 years, the Department of Health and Human Services announced last Friday, according to the New York Times.
The three executives are former CEO Michael Friedman, Howard Udell, the company’s former top lawyer, and Dr. Paul Goldenheim, who was once the chief medical officer of the company. In a nutshell, they pled guilty to intentionally misbranding OxyContin as a safe, non-addictive pain reliever, when in fact they knew those things be untrue.
In 2007, as part of a /files/116785-109034/Plea_Agreement_Friedman.pdf”>Friedman, /files/116785-109034/Plea_Agreement_Udell.pdf”>Udell, each pleaded guilty to criminal charges. As a result, each was banned for 15 years from doing business with federal health care programs.
Notwithstanding the logistics and the sheer size and Mixx Delicious Digg Facebook Twitter